Galapagos NV (GLPG) stock Forecast for 2022 – 2026
Last update: 05-28-2022, 13:51
Sector: HealthcareThe share price of Galapagos NV (GLPG) now
What analysts predict:: $74.4
52-week high/low: $81.12 / $46.41
50/200 Day Moving Average: $62.19 / $57.67
This figure corresponds to the average price over the previous 50/200 days. For Galapagos NV stocks, the 50-day moving average is the resistance level today.
For Galapagos NV stocks, the 200-day moving average is the resistance level today.
Are you interested in Galapagos NV stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Galapagos NV stock price in 2022, 2023, 2024, 2025, 2026. How much will one Galapagos NV share be worth in 2022 - 2026?
When should I take profit in Galapagos NV stock? When should I record a loss on Galapagos NV stock? What are analysts' forecasts for Galapagos NV stock? What is the future of Galapagos NV stock?
We forecast Galapagos NV stock performance using neural networks based on historical data on Galapagos NV stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Galapagos NV stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Galapagos NV shares. This happens once a day.
Historical and forecast chart of Galapagos NV stock
The chart below shows the historical price of Galapagos NV stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Galapagos NV stock price can be found in the table below.
Long-term forecasts by years.
Galapagos NV daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 30 | 59.44 | 58.67 | 60.19 | 2.59 |
| May 31 | 60.06 | 59.22 | 61.22 | 3.37 |
| Jun 01 | 57.96 | 56.87 | 59.56 | 4.74 |
| Jun 02 | 58.73 | 57.91 | 60.11 | 3.80 |
| Jun 03 | 58.07 | 57.24 | 58.77 | 2.66 |
| Jun 04 | 58.14 | 57.59 | 59.54 | 3.39 |
| Jun 05 | 58.64 | 57.37 | 60.16 | 4.87 |
| Jun 06 | 58.01 | 56.73 | 59.17 | 4.29 |
| Jun 07 | 59.29 | 58.66 | 59.95 | 2.19 |
| Jun 08 | 57.69 | 57.04 | 59.30 | 3.96 |
| Jun 09 | 57.16 | 56.46 | 57.58 | 1.98 |
| Jun 10 | 58.33 | 57.61 | 59.30 | 2.94 |
| Jun 11 | 57.37 | 55.78 | 58.69 | 5.22 |
| Jun 12 | 58.31 | 57.37 | 59.27 | 3.31 |
| Jun 13 | 58.29 | 57.11 | 58.92 | 3.18 |
| Jun 14 | 58.76 | 58.04 | 59.58 | 2.66 |
| Jun 15 | 59.72 | 58.07 | 60.52 | 4.21 |
| Jun 16 | 60.56 | 59.67 | 60.98 | 2.20 |
| Jun 17 | 59.71 | 59.23 | 61.13 | 3.21 |
| Jun 18 | 57.69 | 56.49 | 58.51 | 3.57 |
| Jun 19 | 58.17 | 57.13 | 58.92 | 3.14 |
| Jun 20 | 56.60 | 55.77 | 57.69 | 3.45 |
| Jun 21 | 56.48 | 54.92 | 57.67 | 5.00 |
| Jun 22 | 57.31 | 55.81 | 58.44 | 4.71 |
| Jun 23 | 59.20 | 58.02 | 60.11 | 3.61 |
| Jun 24 | 60.69 | 59.12 | 62.28 | 5.35 |
| Jun 25 | 59.20 | 57.80 | 60.01 | 3.84 |
| Jun 26 | 58.35 | 57.44 | 59.56 | 3.70 |
| Jun 27 | 58.50 | 57.86 | 58.95 | 1.88 |
| Jun 28 | 59.05 | 57.96 | 60.31 | 4.07 |
Galapagos NV Daily Price Targets
Galapagos NV Stock Forecast 05-30-2022.
Pessimistic target level: 58.67
Optimistic target level: 60.19
Galapagos NV Stock Forecast 05-31-2022.
Pessimistic target level: 59.22
Optimistic target level: 61.22
Galapagos NV Stock Forecast 06-01-2022.
Pessimistic target level: 56.87
Optimistic target level: 59.56
Galapagos NV Stock Forecast 06-02-2022.
Pessimistic target level: 57.91
Optimistic target level: 60.11
Galapagos NV Stock Forecast 06-03-2022.
Pessimistic target level: 57.24
Optimistic target level: 58.77
Galapagos NV Stock Forecast 06-04-2022.
Pessimistic target level: 57.59
Optimistic target level: 59.54
GLPG (GLPG) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 61.16 | 54.41 | 65.07 | 16.39 |
| Jul. | 65.95 | 60.78 | 69.64 | 12.73 |
| Aug. | 63.74 | 56.50 | 68.53 | 17.56 |
| Sep. | 68.63 | 65.67 | 71.92 | 8.70 |
| Oct. | 72.58 | 67.94 | 77.69 | 12.56 |
| Nov. | 81.53 | 73.18 | 84.27 | 13.16 |
| Dec. | 90.92 | 86.84 | 96.15 | 9.68 |
Galapagos NV forecast for this year
Galapagos NV Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $61.1568. Pessimistic: $54.41. Optimistic: $65.07
Galapagos NV Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $65.9515. Pessimistic: $60.78. Optimistic: $69.64
Galapagos NV Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $63.7355. Pessimistic: $56.50. Optimistic: $68.53
Galapagos NV Stock Prediction for Sep 2022
An uptrend is forecast for this month with an optimal target price of $68.6304. Pessimistic: $65.67. Optimistic: $71.92
Galapagos NV Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $72.5835. Pessimistic: $67.94. Optimistic: $77.69
Galapagos NV Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $81.5258. Pessimistic: $73.18. Optimistic: $84.27
Galapagos NV Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $90.9176. Pessimistic: $86.84. Optimistic: $96.15
Galapagos NV (GLPG) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 85.39 | 75.01 | 90.58 | 17.19 |
| Feb | 78.70 | 73.41 | 87.51 | 16.12 |
| Mar | 86.25 | 82.25 | 90.94 | 9.56 |
| Apr | 78.25 | 69.48 | 87.26 | 20.37 |
| May | 78.50 | 69.33 | 83.65 | 17.12 |
| Jun | 80.76 | 77.66 | 91.09 | 14.75 |
| Jul | 83.08 | 75.11 | 90.79 | 17.28 |
| Aug | 86.27 | 79.65 | 89.31 | 10.82 |
| Sep | 86.96 | 77.92 | 91.14 | 14.50 |
| Oct | 91.00 | 87.07 | 98.57 | 11.67 |
| Nov | 103.52 | 94.08 | 115.28 | 18.39 |
| Dec | 102.03 | 89.95 | 110.36 | 18.49 |
Galapagos NV (GLPG) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 108.40 | 97.47 | 111.87 | 12.87 |
| Feb | 91.05 | 86.39 | 100.23 | 13.81 |
| Mar | 90.47 | 79.90 | 99.30 | 19.53 |
| Apr | 87.57 | 83.09 | 93.88 | 11.49 |
| May | 81.27 | 76.72 | 87.77 | 12.59 |
| Jun | 75.68 | 70.11 | 83.31 | 15.84 |
| Jul | 84.76 | 79.20 | 89.51 | 11.52 |
| Aug | 80.42 | 74.50 | 89.68 | 16.93 |
| Sep | 82.09 | 73.69 | 87.35 | 15.64 |
| Oct | 70.93 | 61.85 | 78.76 | 21.47 |
| Nov | 73.42 | 67.55 | 78.95 | 14.43 |
| Dec | 78.01 | 71.27 | 84.62 | 15.78 |
Galapagos NV (GLPG) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 89.74 | 82.13 | 92.75 | 11.46 |
| Feb | 94.91 | 90.81 | 98.86 | 8.14 |
| Mar | 103.11 | 99.31 | 115.65 | 14.12 |
| Apr | 118.95 | 105.24 | 131.51 | 19.97 |
| May | 111.14 | 98.52 | 122.17 | 19.36 |
| Jun | 113.10 | 106.22 | 117.26 | 9.41 |
| Jul | 126.67 | 113.09 | 140.86 | 19.71 |
| Aug | 132.14 | 127.70 | 141.66 | 9.85 |
| Sep | 134.26 | 126.52 | 145.21 | 12.87 |
| Oct | 122.87 | 108.32 | 126.80 | 14.57 |
| Nov | 116.97 | 103.87 | 120.72 | 13.95 |
| Dec | 111.55 | 100.30 | 115.29 | 13.00 |
Galapagos NV (GLPG) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 125.82 | 113.95 | 135.49 | 15.90 |
| Feb | 131.26 | 118.24 | 146.59 | 19.34 |
| Mar | 139.66 | 126.70 | 144.13 | 12.09 |
| Apr | 138.32 | 129.69 | 146.29 | 11.35 |
| May | 129.91 | 119.10 | 137.81 | 13.57 |
| Jun | 131.57 | 116.63 | 138.73 | 15.93 |
| Jul | 139.78 | 127.03 | 156.33 | 18.74 |
| Aug | 135.31 | 120.16 | 148.52 | 19.10 |
| Sep | 134.88 | 126.89 | 148.47 | 14.53 |
| Oct | 127.54 | 116.32 | 143.46 | 18.92 |
| Nov | 129.38 | 113.23 | 144.49 | 21.63 |
| Dec | 117.37 | 104.79 | 130.14 | 19.48 |
Galapagos NV information and performance
Galapagos NV, a clinical stage biotechnology company, discovers, develops and markets various small molecule drugs. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for rheumatoid arthritis, Crohn’s disease, ulcerative colitis, small bowel CD, fistulizing CD, Sjögren’s syndrome, ankylosing spondylitis, psoriatic arthritis, cutaneous lupus erythematosus, membranous nephropathy lupus and uveitis.
Galapagos NV Address
GEN DE WITTELAAN L11 A3, 2800 MECHELEN, BE
Market Capitalization: 3 612 620 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: N/A
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -2.03
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 20.54
Quarterly Revenue Growth YOY: 0.197
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 1.184
Enterprise Value (EV) /Revenue
EV To EBITDA: 16.11
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 65648000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A